Tenofovir for children and adults with chronic hepatitis B

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.

Saved in:
Bibliographic Details
Main Authors: Li, Huijuan, Yang, Minyan, Ma, Mina, Li, Zijun, Li, Meixuan, Zhu, LongDong, Yao, Liang, Li, Junfeng, Zhong, Linda Lidan, Yang, Kehu
Other Authors: School of Biological Sciences
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/171585
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-171585
record_format dspace
spelling sg-ntu-dr.10356-1715852023-11-06T15:32:08Z Tenofovir for children and adults with chronic hepatitis B Li, Huijuan Yang, Minyan Ma, Mina Li, Zijun Li, Meixuan Zhu, LongDong Yao, Liang Li, Junfeng Zhong, Linda Lidan Yang, Kehu School of Biological Sciences Science::Medicine Chronic Hepatitis B Drug Efficacy Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B. Published version Cochrane Review Group funding acknowledgement: the Danish State is the largest single funder of the Cochrane Hepato-Biliary Group through its investment in the Copenhagen Trial Unit, Centre for Clinical Intervention Research, the Capital Region, Rigshospitalet, Copenhagen, Denmark. 2023-10-31T06:48:53Z 2023-10-31T06:48:53Z 2023 Journal Article Li, H., Yang, M., Ma, M., Li, Z., Li, M., Zhu, L., Yao, L., Li, J., Zhong, L. L. & Yang, K. (2023). Tenofovir for children and adults with chronic hepatitis B. Cochrane Database of Systematic Reviews, 2023(9), 1-17. https://dx.doi.org/10.1002/14651858.CD015586 1469-493X https://hdl.handle.net/10356/171585 10.1002/14651858.CD015586 2-s2.0-85171837437 9 2023 1 17 en Cochrane Database of Systematic Reviews © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. All rights reserved. This article may be downloaded for personal use only. Any other use requires prior permission of the copyright holder. The Version of Record is available online at http://doi.org/10.1002/14651858.CD015586 application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Chronic Hepatitis B
Drug Efficacy
spellingShingle Science::Medicine
Chronic Hepatitis B
Drug Efficacy
Li, Huijuan
Yang, Minyan
Ma, Mina
Li, Zijun
Li, Meixuan
Zhu, LongDong
Yao, Liang
Li, Junfeng
Zhong, Linda Lidan
Yang, Kehu
Tenofovir for children and adults with chronic hepatitis B
description Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Li, Huijuan
Yang, Minyan
Ma, Mina
Li, Zijun
Li, Meixuan
Zhu, LongDong
Yao, Liang
Li, Junfeng
Zhong, Linda Lidan
Yang, Kehu
format Article
author Li, Huijuan
Yang, Minyan
Ma, Mina
Li, Zijun
Li, Meixuan
Zhu, LongDong
Yao, Liang
Li, Junfeng
Zhong, Linda Lidan
Yang, Kehu
author_sort Li, Huijuan
title Tenofovir for children and adults with chronic hepatitis B
title_short Tenofovir for children and adults with chronic hepatitis B
title_full Tenofovir for children and adults with chronic hepatitis B
title_fullStr Tenofovir for children and adults with chronic hepatitis B
title_full_unstemmed Tenofovir for children and adults with chronic hepatitis B
title_sort tenofovir for children and adults with chronic hepatitis b
publishDate 2023
url https://hdl.handle.net/10356/171585
_version_ 1783955512031707136